Pliant Announces Next Steps for Beacon-IPF Trial
Pliant Therapeutics has convened an external expert panel to analyze data from its paused BEACON-IPF Phase 2b trial of...
eClinical Tech News
Orchestra Biomed Announces Favorable AVIM Therapy Data for Heart Failure at THT 2025
Orchestra BioMed Holdings announced positive data from a retrospective analysis of its MODERATO II study, demonstrating that atrioventricular interval...
Ati-2138: Potent, Selective Inhibitor of ITK and JAK3
Aclaris Therapeutics announced the publication of research on ATI-2138, a novel dual inhibitor of ITK and JAK3, currently in...
Corbus Pharmaceuticals Announces Clinical Data for CRB-701
Corbus Pharmaceuticals announced that an abstract for its first-in-human dose-escalation clinical study of CRB-701 (SYS6002) for advanced solid tumors...
Voyager Provides Update on SOD1 ALS Gene Therapy Program
Voyager Therapeutics is halting development of its SOD1 ALS gene therapy, VY9323, after three-month primate data revealed an off-target...
Dr. Sándor Nardai Leads Algernon Phase 2a DMT Stroke Study
Algernon Pharmaceuticals’ subsidiary, Algernon NeuroScience, has appointed Dr. Sándor Nardai as the Principal Investigator for its Phase 2a DMT...
Ampligen® & Flumist®: AIM Immunotech’s Innovative Avian Flu Trial
AIM ImmunoTech Inc. is initiating a plan to further develop Ampligen as a vaccine adjuvant for avian influenza. The...
Eylea HD: 3-Year Results Show Durable Vision Gains in Wet AMD
Regeneron announced positive three-year results from an extension study of the Phase 3 PULSAR trial for EYLEA HD (aflibercept...
CytoDyn Shows Statistically Significant Fibrosis Reversal
CytoDyn Inc. announced positive preclinical results for leronlimab, demonstrating a statistically significant reversal of liver fibrosis in three separate...
Wave Life Sciences Initiates Phase 1 Inlight Trial of WVE-007 in Obesity
Wave Life Sciences has initiated a Phase 1 clinical trial, INLIGHT, for WVE-007, a novel RNA interference (RNAi) therapy...